What is the clinical evidence from this study?

Study design: Review. Population: Diabetes.

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

Cite This Study

Schneider et al. (2012) conducted a review in Diabetes. Type 2 diabetes and insulin resistance predispose patients to an increased risk of premature coronary artery disease and myocardial infarction.

synapsesocial.com/papers/6a6567fafd26db5682d78047 https://doi.org/10.2337/dc12-0638

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome<sup>1</sup>1997 · 452 citations
22010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines2019 · 275 citations
3Methyldopa and propranolol or practolol in moderate hypertension.1976 · 19 citations
4Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes2011 · 48 citations
5Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.1991 · 161 citations

Topics

Coronary artery disease

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

Discussion

Member takes

Implication

PICO

Cite This Study

Topics

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

Discussion

Member takes

Implication

PICO

Cite This Study

Also Consider

Topics

Also Consider